GRFS

Grifols (GRFS)

Grifols SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GRFS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/20	05 : 42	PR Newswire (US)	Grifols 2023 Annual Report on Form 20-F filed with the SEC	NASDAQ:GRFS	Grifols SA
2024/04/18	22 : 30	GlobeNewswire Inc.	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.	NASDAQ:GRFS	Grifols SA
2024/04/15	20 : 06	IH Market News	Samsung Surpasses Apple in Q1 Smartphone Market; Salesforce in Talks to Acquire Informatica, and More News	NASDAQ:GRFS	Grifols SA
2024/04/04	17 : 00	GlobeNewswire Inc.	Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	NASDAQ:GRFS	Grifols SA
2024/03/22	22 : 07	IH Market News	FedEx Soars 13% with Profits Above Forecasts, Nike Hit by China Slowdown, and Latest News	NASDAQ:GRFS	Grifols SA
2024/03/08	20 : 19	IH Market News	CNOOC Oil Field Discovery in South China Sea, Grifols Surges 18% After KPMG Approval, and Latest News	NASDAQ:GRFS	Grifols SA
2024/02/14	17 : 16	GlobeNewswire Inc.	Grifols announces positive topline phase 3 fibrinogen clinical trial results	NASDAQ:GRFS	Grifols SA
2024/01/27	07 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2024/01/16	20 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2024/01/12	20 : 10	IH Market News	Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More	NASDAQ:GRFS	Grifols SA
2024/01/11	03 : 08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2024/01/10	22 : 59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2024/01/10	20 : 21	IH Market News	Wall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and More	NASDAQ:GRFS	Grifols SA
2024/01/10	04 : 49	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2024/01/09	22 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/12/29	23 : 59	Dow Jones News	Grifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down Debt	NASDAQ:GRFS	Grifols SA
2023/12/29	23 : 46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/12/29	23 : 40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/11/16	19 : 00	PR Newswire (US)	Grifols launches new solution to facilitate pre-transfusion compatibility testing in multiple myeloma patients	NASDAQ:GRFS	Grifols SA
2023/11/15	22 : 00	GlobeNewswire Inc.	Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin Deficiency	NASDAQ:GRFS	Grifols SA
2023/11/06	22 : 00	GlobeNewswire Inc.	GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023	NASDAQ:GRFS	Grifols SA
2023/11/03	02 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/10/25	07 : 30	GlobeNewswire Inc.	Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD	NASDAQ:GRFS	Grifols SA
2023/10/20	21 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/10/19	21 : 00	GlobeNewswire Inc.	GigaGen Granted Expansion of Contract with US Department of Defense to Develop Synthetic Human Antibody Treatments for Botulinum Neurotoxins	NASDAQ:GRFS	Grifols SA
2023/09/28	21 : 00	GlobeNewswire Inc.	GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564	NASDAQ:GRFS	Grifols SA
2023/08/01	21 : 00	GlobeNewswire Inc.	Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and Analytics	NASDAQ:GRFS	Grifols SA
2023/07/28	00 : 44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GRFS	Grifols SA
2023/07/20	21 : 15	GlobeNewswire Inc.	Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients	NASDAQ:GRFS	Grifols SA
2023/07/18	21 : 00	GlobeNewswire Inc.	Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis	NASDAQ:GRFS	Grifols SA